HCC
CVS icon

Hirtle Callaghan & Co’s CVS Health CVS Stock Holding History

Hirtle Callaghan & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,680
Closed -$176K – 85
2018
Q4 		$176K Buy
+2,680
New +$200K 0.02% 88
2017
Q4 		– Sell
-406
Closed -$33K – 169
2017
Q3 		$33K Hold
406
– – ﹤0.01% 120
2017
Q2 		$32K Sell
406
-100
-20% -$7.9K 0.01% 94
2017
Q1 		$40K Hold
506
– – 0.01% 90
2016
Q4 		$40K Sell
506
-342
-40% -$27.7K 0.01% 73
2016
Q3 		$75K Sell
848
-187
-18% -$17.7K 0.02% 114
2016
Q2 		$99K Sell
1,035
-177
-15% -$17.6K 0.02% 99
2016
Q1 		$125K Sell
1,212
-2,233
-65% -$217K 0.02% 107
2015
Q4 		$337K Sell
3,445
-532
-13% -$52.1K 0.08% 25
2015
Q3 		$381K Hold
3,977
– – 0.07% 34
2015
Q2 		$417K Buy
+3,977
New +$406K 0.14% 30
2015
Q1 		– Sell
-2,906
Closed -$280K – 98
2014
Q4 		$280K Hold
2,906
– – 0.06% 165
2014
Q3 		$231K Hold
2,906
– – 0.04% 178
2014
Q2 		$219K Buy
2,906
+3
+0.1% +$227 0.03% 229
2014
Q1 		$217K Buy
2,903
+3
+0.1% +$212 0.04% 229
2013
Q4 		$208K Hold
2,900
– – 0.03% 223
2013
Q3 		$165K Buy
+2,900
New +$173K 0.03% 238

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hirtle Callaghan & Co's CVS Position: Q1 2019 in Review

Hirtle Callaghan & Co sold out of CVS Health (CVS) in Q1 2019, closing a stake of 2,680 shares — an estimated $176K sold.

Hirtle Callaghan & Co first reported a position in CVS in Q3 2013 and held it in 17 quarters. The position peaked at $417K in Q2 2015. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

  • Hirtle Callaghan & Co reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 2,680 CVS Health shares in Q1 2019, an estimated $176K.
  • Hirtle Callaghan & Co first reported a position in CVS Health in Q3 2013 and held it in 17 quarters.
  • Hirtle Callaghan & Co's CVS Health position peaked at $417K in Q2 2015.
  • 1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2019, filed 14 May 2019.